MPM BioVentures 2018 GP LLC's Net Worth
$144 Million
Who is MPM BioVentures 2018 GP LLC?
MPM BioVentures 2018 GP LLC has an estimated net worth of $144 Million. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., Entrada Therapeutics, Inc., and Dyne Therapeutics, Inc..
SEC CIK
MPM BioVentures 2018 GP LLC's CIK is 0001818701
Past Insider Trading and Trends
2020 was MPM BioVentures 2018 GP LLC's most active year for acquiring shares with 21 total transactions. MPM BioVentures 2018 GP LLC's most active month to acquire stocks was the month of June. 2021 was MPM BioVentures 2018 GP LLC's most active year for disposing of shares, totalling 72 transactions. MPM BioVentures 2018 GP LLC's most active month to dispose stocks was the month of August. 2021 saw MPM BioVentures 2018 GP LLC paying a total of $2,000,000.00 for 4,425,784 shares, this is the most they've acquired in one year. In 2022 MPM BioVentures 2018 GP LLC cashed out on 146,685 shares for a total of $6,246,049.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.95M |
—
|
—
| 4.95M |
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
iTeos Therapeutics, Inc. (ITOS) Snapshot price: $10
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.08% | -146.69K |
$42.58 | -$6,246,049.63 | 2.74M |
Jan 4 - Jan 5
| |||
Form 4
| -1.70% | -49.83K |
$33.73 | -$1,680,611.12 | 2.89M |
Scheduled
|
Dec 3 - Dec 7
| ||
Form 4
| -1.40% | -83.52K |
$34.63 | -$2,878,562.19 | 5.88M |
Scheduled
|
Nov 30 - Dec 2
| ||
Form 4
| -0.76% | -23.05K |
$35.18 | -$810,765.76 | 3.02M |
Scheduled
|
Nov 26 - Nov 29
| ||
Form 4
| -2.97% | -93.13K |
$36.61 | -$2,835,263.01 | 3.04M |
Scheduled
|
Nov 17 - Nov 24
| ||
Form 4
| -0.54% | -17.10K |
$27.45 | -$469,309.06 | 3.13M |
Scheduled
|
Oct 15 - Oct 18
| ||
Form 4
| -1.77% | -56.77K |
$27.21 | -$1,544,473.66 | 3.15M |
Scheduled
|
Oct 12 - Oct 14
| ||
Form 4
| -1.59% | -51.99K |
$27.23 | -$1,415,546.20 | 3.21M |
Scheduled
|
Oct 7 - Oct 11
| ||
Form 4
| -0.84% | -27.57K |
$27.05 | -$745,524.66 | 3.26M |
Scheduled
|
Oct 1 - Oct 4
| ||
Form 4
| -0.65% | -21.51K |
$27.00 | -$580,662.00 | 3.29M |
Scheduled
|
Sep 28 - Sep 30
| ||
Form 4
| -1.59% | -53.47K |
$27.76 | -$1,484,415.72 | 3.31M |
Scheduled
|
Sep 23 - Sep 27
| ||
Form 4
| -1.00% | -33.93K |
$27.50 | -$933,030.21 | 3.36M |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
| -2.62% | -91.25K |
$28.38 | -$2,590,097.17 | 3.4M |
Scheduled
|
Sep 16 - Sep 20
| ||
Form 4
| -1.29% | -45.66K |
$27.70 | -$1,264,909.69 | 3.49M |
Scheduled
|
Sep 14 - Sep 15
| ||
Form 4
| -1.60% | -57.64K |
$28.32 | -$1,632,261.44 | 3.53M |
Scheduled
|
Sep 9 - Sep 13
| ||
Form 4
| -0.68% | -73.91K |
$28.92 | -$1,235,644.04 | 10.83M |
Scheduled
|
Sep 7 - Sep 8
| ||
Form 4
| -0.00% | -119.00 |
$29.99 | -$3,568.81 | 3.67M |
Scheduled
|
Apr 9
| ||
Form 4
| -0.55% | -40.76K |
$31.00 | -$777,342.98 | 7.32M |
Scheduled
|
Apr 7 - Apr 8
| ||
Form 4
| +63.86% | 3.71M |
$19.00 | $3,040,000.00 | 9.51M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $13.74
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.43M |
$20.00 |
—
| 4.43M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |